Baudax Bio to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

Nov 15, 2021 7:00am EST

Baudax Bio Announces Clinical Program Update for Neuromuscular Blocking Agents BX-1000, BX-2000 and BX-3000

Nov 11, 2021 7:00am EST

Baudax Bio Reports Third Quarter 2021 Financial Results and Business Highlights

Nov 04, 2021 7:00am EDT

Baudax Bio to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 4, 2021

Oct 28, 2021 7:00am EDT

Baudax Bio to Present at the NobleCon Pain Management Investor Forum

Oct 05, 2021 7:00am EDT

Baudax Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Oct 01, 2021 4:17pm EDT

Baudax Bio to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Sep 16, 2021 7:00am EDT

Baudax Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Sep 07, 2021 7:00am EDT

Baudax Bio Reports Second Quarter 2021 Financial Results and Highlights

Aug 05, 2021 7:00am EDT

Baudax Bio Announces Date of Reconvened Special Meeting

Jul 30, 2021 4:05pm EDT